|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.60 HKD | +2.27% |
|
-1.79% | -3.23% |
| 03-16 | Abbisko Doses First Patient in Liver Cancer Drug Trial | MT |
| 03-11 | Abbisko Drug Receives Rare Pediatric Designation in U.S. | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.27% | -1.79% | -4.55% | -6.95% | -3.23% | +58.36% | +316.89% | - | - | 1.04B | |
| +0.49% | -2.19% | -11.61% | -15.11% | -13.95% | +11.94% | +81.73% | +131.88% | +6,068.00% | 42.98B | |
| +0.25% | 0.00% | -10.61% | +2.22% | +0.51% | +42.54% | +19.44% | -16.23% | - | 39.24B | |
| +3.66% | +1.03% | -2.79% | -27.94% | -16.92% | +88.90% | +728.18% | +306.98% | +1,172.89% | 30.07B | |
| -0.71% | -11.37% | -14.48% | -1.83% | -4.89% | -8.98% | -31.39% | -16.24% | - | 21.88B | |
| +2.47% | -2.73% | -11.61% | +9.47% | +13.30% | +33.91% | -25.79% | -61.62% | - | 18.25B | |
| +0.70% | -0.61% | -8.36% | -13.69% | -15.42% | +21.25% | -31.77% | -19.32% | +106.57% | 16.03B | |
| +2.57% | +3.04% | +8.62% | +1.20% | +4.87% | +65.62% | +157.61% | +150.00% | - | 12.97B | |
| +0.34% | +2.89% | +8.12% | -6.12% | -7.52% | -22.20% | +783.88% | +164.73% | +137.87% | 12.5B | |
| +2.98% | +2.80% | +2.06% | +4.57% | +8.41% | +70.08% | - | - | - | 11.76B | |
| -0.41% | -3.07% | -6.49% | -1.27% | -6.30% | +12.06% | +132.17% | +74.25% | +1,013.01% | 10.71B | |
| -0.90% | +1.76% | -5.14% | -20.51% | -24.30% | +26.55% | +79.29% | +278.20% | - | 10.2B | |
| -3.20% | +0.98% | -14.59% | -27.67% | -30.69% | - | - | - | - | 8.83B | |
| -2.15% | -2.84% | +38.10% | +280.09% | +314.65% | +186.06% | +482.27% | -74.64% | - | 8.63B | |
| +4.97% | +5.81% | +15.63% | +22.19% | +31.53% | +398.42% | +79.19% | -10.66% | - | 8.06B | |
| +1.91% | -6.24% | +2.81% | +27.36% | +20.55% | -25.21% | +45.72% | +108.16% | - | 7.86B | |
| +4.21% | -5.44% | -10.11% | -11.27% | -13.59% | +273.50% | +134.74% | -20.29% | +1,262.71% | 7.71B | |
| +1.63% | -2.73% | -1.28% | -3.03% | -1.06% | +29.24% | +236.01% | - | - | 7.7B | |
| -1.22% | -2.70% | -10.48% | +27.01% | +38.09% | +29.54% | +62.94% | +573.10% | +299.90% | 7.59B | |
| +1.28% | -2.55% | -8.19% | -1.92% | -4.27% | +37.13% | +64.14% | +154.73% | +885.90% | 7.4B | |
| Average | +0.93% | -1.79% | -2.25% | +11.84% | +14.49% | +69.93% | +184.18% | +107.69% | +1,368.35% | 14.57B | |
| Weighted average by Cap. | +0.92% | -2.21% | -4.91% | +3.16% | +5.33% | +52.82% | +176.76% | +97.56% | +2,436.69% |
- Stock Market
- Equities
- 2256 Stock
- Sector Abbisko Cayman Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition